Professor of Pathology
Harvard Medical School;
Emeritus Chief of Onco-Pathology
Dana-Farber Cancer Institute;
Emeritus Vice Chair of Anatomic Pathology;
Brigham and Women’s Hospital
Boston, MA
For breakthrough discoveries that have led to the molecular characterization of soft tissue tumors, and for transforming the cancer pathology field by providing expert insights into tumor diagnosis and clinical prognosis. Dr. Fletcher was the first to integrate morphological aspects of soft tissues with the characterization of genetic insults leading to the definition of over 40 distinct molecular and morphological characteristics capable of classifying mesenchymal neoplasms. These categorized molecular signatures have since contributed to the establishment of innovative therapies for cancer patients worldwide.
The AACR established this award in 2021 to recognize and celebrate pathologists who have significantly
contributed to advancing cancer research, diagnosis, treatment, and prevention.
To learn more please visit the press release.
View Past Recipient.